EX-23.2 2 ex23-2.htm CONSENT OF OUM & CO. LLP ex23-2.htm
Exhibit 23.2
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the use, in the Prospectus constituting a part of this Registration Statement on Form S-1, of our report dated June 29, 2015 (which report expresses an unqualified opinion and includes an emphasis of matter paragraph concerning the ability of VistaGen Therapeutics, Inc. to continue as a going concern) relating to the consolidated financial statements of VistaGen Therapeutics, Inc., which is contained in that Prospectus.
 
We also consent to the reference to us under the caption “Experts” in the Prospectus.
 
 
/s/ OUM & CO. LLP

San Francisco, California
 
July 20, 2015